MedPath

A RANDOMISED ALLOCATED CLINICAL STUDY TO EVALUATE THE ANTI DIABETIC EFFECT OF SULPHUR, PHOSPHORUS AND THUJA OCCIDENTALIS

Phase 4
Conditions
Health Condition 1: E119- Type 2 diabetes mellitus without complications
Registration Number
CTRI/2024/03/063404
Lead Sponsor
Self
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.patients of ore diagnosed diabetes mellitus will be included

2.age group between 30-75years will be included

3.patients agreed for control group treatment

4patients opting for homoeopathic treatment with written consent form and regular follow up

Exclusion Criteria

1.pregnant and lactating women

2.pateints with severe comorbidities pertaining to diabetes mellitus

3.patients with more than 200 fbs, 300 ppbs, 9% Hba1c

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath